Page last updated: 2024-12-08

cucurbit(6)uril

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

cucurbit(6)uril: a macrocyclic cavitand comprising six GLYCOLURIL units; can be used for creating ROTAXANES [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

cucurbituril : A macrocycle consisting of repeating 2,5-dioxodihydroimidazo[4,5-d]imidazole-1,3,4,6-tetrayl (glycoluril) units linked by methylene groups. The number of glycoluril units in the macrocycle is denoted by the "n" in cucurbit[n]uril name. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID196163
CHEBI ID51432
SCHEMBL ID39370
SCHEMBL ID13527759
SCHEMBL ID16272338
MeSH IDM0424695

Synonyms (25)

Synonym
cucurbit[6]uril
cucurbituril
cb[6]
80262-44-8
dodecahydro-1h,4h,14h,17h-2,16:3,15-dimethano-5h,6h,7h,8h,9h,10h,11h,12h,13h,18h,19h,20h,21h,22h,23h,24h,25h,26h-2,3,4a,5a,6a,7a,8a,9a,10a,11a,12a,13a,15,16,17a,18a,19a,20a,21a,22a,23a,24a,25a,26a-tetracosaazabispentaleno[1''',6''':5'',6'',7'']cycloocta[1
CHEBI:51432
cucurbit(6)uril
cucurbit[6]uril hydrate
SCHEMBL39370
SCHEMBL13527759
mfcd10567435
cucurbit[6]uril (cb[6]) hydrate, 99%
SCHEMBL16272338
Q413979
CS-0188440
BS-17595
MSBXTPRURXJCPF-UHFFFAOYSA-N
Q27122602
3,5,8,10,13,15,18,20,23,25,28,30,31,33,35,37,41,43,45,47,49,51,53,55-tetracosazanonadecacyclo[25.3.3.3^{6,7.3^{11,12.3^{16,17.3^{21,22.2^{2,31.2^{26,33.1^{3,30.1^{5,8.1^{10,13.1^{15,18.1^{20,23.1^{25,28.1^{35,41.1^{37,55.1^{43,45.1^{47,49.1^{51,53]hexacon
cucurbit[n]uril b
3,5,8,10,13,15,18,20,23,25,28,30,31,33,35,37,41,43,45,47,49,51,53,55-tetracosazanonadecacyclo[25.3.3.36,7.311,12.316,17.321,22.22,31.226,33.13,30.15,8.110,13.115,18.120,23.125,28.135,41.137,55.143,45.147,49.151,53]hexacontane-34,36,38,39,40,42,44,46,48,50
A864715
D82910
DTXSID101317823
HY-W130354

Research Excerpts

Compound-Compound Interactions

ExcerptReferenceRelevance
" This work presents the first description of CB6 in combination with a new guanidinium-based ionic liquid (GBIL) as the GC stationary phase by using sol-gel coating method for the preparation of the CB6-GBIL and GBIL columns."( Cucurbit[6]uril in combination with guanidinium ionic liquid as a new type of stationary phase for capillary gas chromatography.
Fu, R; Qi, M; Wang, L; Wang, X, 2014
)
0.4

Bioavailability

ExcerptReferenceRelevance
" The present study focuses on the effect of hydroxy cucurbit[6]uril on the bioavailability of hydrocarbons."( Biodegradation of aliphatic hydrocarbons in the presence of hydroxy cucurbit[6]uril.
Banerjee, M; Chandrasekharan, S; Ganguly, A; Kumar, V; Mutnuri, S; Pasumarthi, R, 2014
)
0.4

Dosage Studied

ExcerptRelevanceReference
" Cucurbit[6]uril was formulated into both buffered cream aqueous- and oily cream-based dosage forms."( Topical cream-based dosage forms of the macrocyclic drug delivery vehicle cucurbit[6]uril.
Apps, MG; Impelido, ML; Seif, M; Wheate, NJ, 2014
)
0.4
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (111)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's49 (44.14)29.6817
2010's52 (46.85)24.3611
2020's10 (9.01)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 29.70

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index29.70 (24.57)
Research Supply Index4.73 (2.92)
Research Growth Index4.53 (4.65)
Search Engine Demand Index34.57 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (29.70)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (1.79%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other110 (98.21%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]